NRx Pharmaceuticals, Inc. (NRXP) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts NRXP Hot Sheet
Join SI Premium – FREE
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) reported Q3 EPS of ($0.14), in-line with the analyst estimate of ($0.14).
For earnings history and earnings-related data on NRx Pharmaceuticals, Inc. (NRXP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- Surf Air Mobility names Palantir veteran as president of SurfOS
- B. Riley previews Semi Cap Equipment sector ahead of Semicon West
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
